• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用表达克里米亚-刚果出血热病毒糖蛋白的转基因植物经口免疫的小鼠。

Mice orally immunized with a transgenic plant expressing the glycoprotein of Crimean-Congo hemorrhagic fever virus.

作者信息

Ghiasi S M, Salmanian A H, Chinikar S, Zakeri S

机构信息

Department of Plant Biotechnology, National Institute of Genetic Engineering and Biotechnology, Shahrak-e-Pajoohesh, 15th Km, Tehran-Karaj Highway, P.O. Box 14965-161, Tehran, Iran.

出版信息

Clin Vaccine Immunol. 2011 Dec;18(12):2031-7. doi: 10.1128/CVI.05352-11. Epub 2011 Oct 19.

DOI:10.1128/CVI.05352-11
PMID:22012978
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3232705/
Abstract

While Crimean-Congo hemorrhagic fever (CCHF) has a high mortality rate in humans, the associated virus (CCHFV) does not induce clinical symptoms in animals, but animals play an important role in disease transmission to humans. Our aim in this study was to examine the immunogenicity of the CCHFV glycoprotein when expressed in the root and leaf of transgenic plants via hairy roots and stable transformation of tobacco plants, respectively. After confirmatory analyses of transgenic plant lines and quantification of the expressed glycoprotein, mice were either fed with the transgenic leaves or roots, fed the transgenic plant material and injected subcutaneously with the plant-made CCHFV glycoprotein (fed/boosted), vaccinated with an attenuated CCHF vaccine (positive control), or received no treatment (negative control). All immunized groups had a consistent rise in anti-glycoprotein IgG and IgA antibodies in their serum and feces, respectively. The mice in the fed/boosted group showed a significant rise in specific IgG antibodies after a single boost. Our results imply that oral immunization of animals with edible materials from transgenic plants is feasible, and further assessments are under way. In addition, while the study of CCHF is challenging, our protocol should be further used to study CCHFV infection in the knockout mouse model and virus neutralization assays in biosafety level 4 laboratories.

摘要

虽然克里米亚-刚果出血热(CCHF)在人类中的死亡率很高,但相关病毒(CCHFV)不会在动物中引发临床症状,不过动物在疾病传播给人类的过程中起着重要作用。我们在本研究中的目的是分别通过发根和烟草植物的稳定转化来检测CCHFV糖蛋白在转基因植物的根和叶中表达时的免疫原性。在对转基因植物株系进行确证分析并对表达的糖蛋白进行定量后,给小鼠喂食转基因叶或根,喂食转基因植物材料并皮下注射植物源CCHFV糖蛋白(喂食/加强免疫),用减毒CCHF疫苗进行免疫接种(阳性对照),或不进行处理(阴性对照)。所有免疫组血清和粪便中的抗糖蛋白IgG和IgA抗体均出现持续上升。喂食/加强免疫组的小鼠在单次加强免疫后,特异性IgG抗体显著上升。我们的结果表明,用转基因植物的可食用材料对动物进行口服免疫是可行的,进一步的评估正在进行中。此外,虽然对CCHF的研究具有挑战性,但我们的方案应进一步用于在基因敲除小鼠模型中研究CCHFV感染以及在生物安全4级实验室中进行病毒中和试验。

相似文献

1
Mice orally immunized with a transgenic plant expressing the glycoprotein of Crimean-Congo hemorrhagic fever virus.用表达克里米亚-刚果出血热病毒糖蛋白的转基因植物经口免疫的小鼠。
Clin Vaccine Immunol. 2011 Dec;18(12):2031-7. doi: 10.1128/CVI.05352-11. Epub 2011 Oct 19.
2
Nucleoside-Modified mRNA Vaccines Protect IFNAR Mice against Crimean-Congo Hemorrhagic Fever Virus Infection.核苷修饰的 mRNA 疫苗可保护 IFNAR 小鼠免受克里米亚-刚果出血热病毒感染。
J Virol. 2022 Feb 9;96(3):e0156821. doi: 10.1128/JVI.01568-21. Epub 2021 Nov 24.
3
A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models.一种用于克里米亚-刚果出血热的DNA疫苗在两种致死性小鼠模型中可预防疾病和死亡。
PLoS Negl Trop Dis. 2017 Sep 18;11(9):e0005908. doi: 10.1371/journal.pntd.0005908. eCollection 2017 Sep.
4
Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.用编码克里米亚-刚果出血热病毒衣壳蛋白和包膜蛋白的DNA质粒及/或病毒样颗粒进行免疫可诱导受攻击小鼠产生保护作用并使其存活。
J Virol. 2017 Apr 28;91(10). doi: 10.1128/JVI.02076-16. Print 2017 May 15.
5
Establishment of two serological methods for detecting IgG and neutralizing antibodies against Crimean-Congo hemorrhagic fever virus glycoprotein.建立两种检测克里米亚-刚果出血热病毒糖蛋白 IgG 和中和抗体的血清学方法。
Front Cell Infect Microbiol. 2024 Apr 30;14:1341332. doi: 10.3389/fcimb.2024.1341332. eCollection 2024.
6
A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease.一种表达核蛋白的克里米亚-刚果出血热(CCHF)病毒疫苗具有免疫原性,但无法提供针对致死性疾病的保护。
Hum Vaccin Immunother. 2016;12(2):519-27. doi: 10.1080/21645515.2015.1078045.
7
Identification of broadly neutralizing monoclonal antibodies against Crimean-Congo hemorrhagic fever virus.鉴定抗克里米亚-刚果出血热病毒的广谱中和单克隆抗体。
Antiviral Res. 2017 Oct;146:112-120. doi: 10.1016/j.antiviral.2017.08.014. Epub 2017 Aug 24.
8
Construction and evaluation of DNA vaccine encoding Crimean Congo hemorrhagic fever virus nucleocapsid protein, glycoprotein N-terminal and C-terminal fused with LAMP1.构建并评价与 LAMP1 融合表达克里米亚-刚果出血热病毒核衣壳蛋白、糖蛋白 N 端和 C 端的 DNA 疫苗
Front Cell Infect Microbiol. 2023 Mar 21;13:1121163. doi: 10.3389/fcimb.2023.1121163. eCollection 2023.
9
Efficient production of a lentiviral system for displaying Crimean-Congo hemorrhagic fever virus glycoproteins reveals a broad range of cellular susceptibility and neutralization ability.高效生产展示克里米亚-刚果出血热病毒糖蛋白的慢病毒系统揭示了广泛的细胞易感性和中和能力。
Arch Virol. 2020 May;165(5):1109-1120. doi: 10.1007/s00705-020-04576-9. Epub 2020 Mar 18.
10
A novel double-antigen sandwich ELISA for the species-independent detection of Crimean-Congo hemorrhagic fever virus-specific antibodies.一种用于物种非特异性检测克里米亚-刚果出血热病毒特异性抗体的新型双抗原夹心 ELISA。
Antiviral Res. 2018 Mar;151:24-26. doi: 10.1016/j.antiviral.2018.01.006. Epub 2018 Jan 9.

引用本文的文献

1
Molecular Evolution and Phylogeography of the Crimean-Congo Hemorrhagic Fever Virus.克里米亚-刚果出血热病毒的分子进化与系统地理学
Viruses. 2025 Jul 28;17(8):1054. doi: 10.3390/v17081054.
2
Crimean-Congo haemorrhagic fever (CCHF): present and future therapeutic armamentarium.克里米亚-刚果出血热(CCHF):当前及未来的治疗手段
Infez Med. 2024 Dec 1;32(4):421-433. doi: 10.53854/liim-3204-2. eCollection 2024.
3
Cellular immunity to nucleoproteins (NP) of Crimean-Congo hemorrhagic fever virus (CCHFV) and Hazara Virus (HAZV).细胞免疫对克里米亚-刚果出血热病毒(CCHFV)和哈扎拉病毒(HAZV)的核蛋白(NP)的反应。
Med Microbiol Immunol. 2024 Sep 25;213(1):20. doi: 10.1007/s00430-024-00802-2.
4
Crimean-Congo Hemorrhagic Fever Virus for Clinicians-Diagnosis, Clinical Management, and Therapeutics.克里米亚-刚果出血热病毒临床医师诊疗手册:诊断、临床管理和治疗。
Emerg Infect Dis. 2024 May;30(5):864-873. doi: 10.3201/eid3005.231648.
5
CCHFV vaccine development, current challenges, limitations, and future directions.CCHFV 疫苗的研发、当前的挑战、局限性和未来方向。
Front Immunol. 2023 Sep 11;14:1238882. doi: 10.3389/fimmu.2023.1238882. eCollection 2023.
6
Crimean-Congo Hemorrhagic Fever Virus: Progress in Vaccine Development.克里米亚-刚果出血热病毒:疫苗研发进展
Diagnostics (Basel). 2023 Aug 19;13(16):2708. doi: 10.3390/diagnostics13162708.
7
Evaluation of the immunogenicity of a Crimean-Congo hemorrhagic fever virus vaccine candidate in mice developed based on a baculovirus Zera nanoparticle delivery system.基于杆状病毒Zera纳米颗粒递送系统开发的克里米亚-刚果出血热病毒候选疫苗在小鼠体内的免疫原性评估。
Front Vet Sci. 2023 Jun 1;10:1126785. doi: 10.3389/fvets.2023.1126785. eCollection 2023.
8
Advances and perspectives in the development of vaccines against highly pathogenic bunyaviruses.高致病性布尼亚病毒疫苗研发的进展与展望。
Front Cell Infect Microbiol. 2023 May 18;13:1174030. doi: 10.3389/fcimb.2023.1174030. eCollection 2023.
9
Plant-made vaccines against viral diseases in humans and farm animals.用于人类和家畜病毒性疾病的植物源疫苗。
Front Plant Sci. 2023 Mar 28;14:1170815. doi: 10.3389/fpls.2023.1170815. eCollection 2023.
10
Evaluation of the immunogenicity of vaccine candidates developed using a baculovirus surface display system for Crimean-Congo hemorrhagic fever virus in mice.使用杆状病毒表面展示系统研发的克里米亚-刚果出血热病毒候选疫苗在小鼠体内的免疫原性评估。
Front Microbiol. 2023 Mar 16;14:1107874. doi: 10.3389/fmicb.2023.1107874. eCollection 2023.

本文引用的文献

1
Immunogenicity of a plant-derived edible chimeric EspA, Intimin and Tir of Escherichia coli O157:H7 in mice.植物源可食性大肠杆菌 O157:H7 嵌合 EspA、肠侵袭蛋白和 Tir 的免疫原性研究。
Plant Sci. 2011 Apr;180(4):620-7. doi: 10.1016/j.plantsci.2011.01.004. Epub 2011 Jan 15.
2
Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice.埃博拉病毒糖蛋白 Fc 融合蛋白赋予接种疫苗的小鼠免受致死性挑战的保护。
Vaccine. 2011 Apr 5;29(16):2968-77. doi: 10.1016/j.vaccine.2011.01.113. Epub 2011 Feb 15.
3
The Bulgarian vaccine Crimean-Congo haemorrhagic fever virus strain.保加利亚克里米亚-刚果出血热病毒株疫苗。
Scand J Infect Dis. 2011 Mar;43(3):225-9. doi: 10.3109/00365548.2010.540036. Epub 2010 Dec 9.
4
Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model.克里米亚-刚果出血热病毒在 STAT-1 敲除小鼠模型中的发病机制和免疫反应。
J Virol. 2010 Nov;84(21):11089-100. doi: 10.1128/JVI.01383-10. Epub 2010 Aug 25.
5
Recent advances in Ebolavirus vaccine development.埃博拉病毒疫苗研发的最新进展。
Hum Vaccin. 2010 Jun;6(6):439-49. doi: 10.4161/hv.6.6.11097. Epub 2010 Jun 1.
6
Prospects for immunisation against Marburg and Ebola viruses.针对马尔堡病毒和埃博拉病毒的免疫前景。
Rev Med Virol. 2010 Nov;20(6):344-57. doi: 10.1002/rmv.661.
7
Crimean-Congo hemorrhagic fever in Europe: current situation calls for preparedness.欧洲的克里米亚-刚果出血热:当前形势需要做好准备。
Euro Surveill. 2010 Mar 11;15(10):19504.
8
Purification and characterization of a viral chitinase active against plant pathogens and herbivores from transgenic tobacco.从转基因烟草中纯化和鉴定一种对植物病原体和草食性昆虫具有活性的病毒几丁质酶。
J Biotechnol. 2010 May 3;147(1):1-6. doi: 10.1016/j.jbiotec.2010.03.005. Epub 2010 Mar 17.
9
Immunogenicity of recombinant GP5 protein of porcine reproductive and respiratory syndrome virus expressed in tobacco plant.在烟草植物中表达的猪繁殖与呼吸综合征病毒重组GP5蛋白的免疫原性
Vet Immunol Immunopathol. 2010 Jun 15;135(3-4):234-42. doi: 10.1016/j.vetimm.2009.12.003. Epub 2009 Dec 22.
10
Crimean-Congo hemorrhagic fever in Iran and neighboring countries.伊朗及邻国的克里米亚-刚果出血热疫情。
J Clin Virol. 2010 Feb;47(2):110-4. doi: 10.1016/j.jcv.2009.10.014. Epub 2009 Dec 16.